Summit Securities Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Hold
0
1172
2022
Q4
Hold
0
1183
2019
Q3
Hold
0
247
2019
Q2
Hold
0
226